Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Biopharmaceuticals

CTech 24/7

  • Italy and Israeli spyware firm Paragon cut ties amid surveillance scandal
  • Unibeam secures $6 million in Seed to expand SIM-based authentication technology
  • Check Point's Gil Shwed reflects on stepping down: “I may regret not doing it earlier”
  • French New (tech) Wave: The country’s foray into high-tech is cementing Macron’s legacy
More stories in CTech

Biopharmaceuticals

3 stories about Biopharmaceuticals
  • Silenseed and Silenseed-China CEO Dr. Amotz Shemi. Photo: PR

    Silenseed signs $7.8 million agreement with GIBF to create Chinese subsidiary

    05.10.21|James SpiroProceeds from the investment are expected to provide Silenseed with liquidity to fund the company’s Phase III clinical trial

  •  KAHR Medical CEO Yaron Pereg. Photo: KAHR Medical

    Cancer Treatment Company KAHR Medical Raises $18 Million

    25.02.20|CTechThe company intends to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107, tested for the treatment of solid tumors

  • Hospital (Illustrative). Photo: Tommy Harpaz

    InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

    28.03.18|Lilach BaumerAs part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive